These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 26250536

  • 1. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
    Konishi Y, Takahashi S, Nishi K, Sakamaki T, Mitani S, Kaneko H, Mizutani C, Ukyo N, Hirata H, Tsudo M.
    Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
    [Abstract] [Full Text] [Related]

  • 2. Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome.
    Yamaga Y, Tokuyama K, Kato T, Yamada R, Murayama M, Ikeda T, Yamakita N, Kunieda T.
    Intern Med; 2016 Aug; 55(2):185-90. PubMed ID: 26781021
    [Abstract] [Full Text] [Related]

  • 3. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
    Sakai K, Maeda T, Kuriyama A, Shimada N, Notohara K, Ueda Y.
    Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of rituximab for TAFRO syndrome, a variant type of multicentric Castleman's disease].
    Ozawa T, Kosugi S, Kito M, Onishi M, Kida T, Nakata S, Take H, Katagiri S.
    Rinsho Ketsueki; 2014 Mar; 55(3):350-5. PubMed ID: 24681940
    [Abstract] [Full Text] [Related]

  • 5. CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman's disease.
    Kiguchi T, Sato C, Takai K, Nakai Y, Kaneko Y, Matsuki M.
    Clin Radiol; 2017 Oct; 72(10):905.e1-905.e5. PubMed ID: 28629605
    [Abstract] [Full Text] [Related]

  • 6. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
    Kubokawa I, Yachie A, Hayakawa A, Hirase S, Yamamoto N, Mori T, Yanai T, Takeshima Y, Kyo E, Kageyama G, Nagai H, Uehara K, Kojima M, Iijima K.
    BMC Pediatr; 2014 Jun 02; 14():139. PubMed ID: 24890946
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
    Fujiwara S, Mochinaga H, Nakata H, Ohshima K, Matsumoto M, Uchiba M, Mikami Y, Hata H, Okuno Y, Mitsuya H, Nosaka K.
    Int J Hematol; 2016 Jun 02; 103(6):718-23. PubMed ID: 26980221
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.
    Nara M, Komatsuda A, Itoh F, Kaga H, Saitoh M, Togashi M, Kameoka Y, Wakui H, Takahashi N.
    Intern Med; 2017 Jun 02; 56(10):1247-1252. PubMed ID: 28502946
    [Abstract] [Full Text] [Related]

  • 18. Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.
    Iwaki N, Sato Y, Takata K, Kondo E, Ohno K, Takeuchi M, Orita Y, Nakao S, Yoshino T.
    J Clin Exp Hematop; 2013 Jun 02; 53(1):87-93. PubMed ID: 23801139
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.